JP2019505164A5 - - Google Patents

Download PDF

Info

Publication number
JP2019505164A5
JP2019505164A5 JP2018522671A JP2018522671A JP2019505164A5 JP 2019505164 A5 JP2019505164 A5 JP 2019505164A5 JP 2018522671 A JP2018522671 A JP 2018522671A JP 2018522671 A JP2018522671 A JP 2018522671A JP 2019505164 A5 JP2019505164 A5 JP 2019505164A5
Authority
JP
Japan
Prior art keywords
protein
host cell
fucose
culture
fucose source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018522671A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019505164A (ja
JP6983772B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/059922 external-priority patent/WO2017079165A1/en
Publication of JP2019505164A publication Critical patent/JP2019505164A/ja
Publication of JP2019505164A5 publication Critical patent/JP2019505164A5/ja
Application granted granted Critical
Publication of JP6983772B2 publication Critical patent/JP6983772B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018522671A 2015-11-02 2016-11-01 タンパク質のフコシル化及び脱フコシル化形態の作製方法 Active JP6983772B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562249828P 2015-11-02 2015-11-02
US62/249,828 2015-11-02
US201662338280P 2016-05-18 2016-05-18
US62/338,280 2016-05-18
PCT/US2016/059922 WO2017079165A1 (en) 2015-11-02 2016-11-01 Methods of making fucosylated and afucosylated forms of a protein

Publications (3)

Publication Number Publication Date
JP2019505164A JP2019505164A (ja) 2019-02-28
JP2019505164A5 true JP2019505164A5 (cg-RX-API-DMAC7.html) 2019-12-12
JP6983772B2 JP6983772B2 (ja) 2021-12-17

Family

ID=57326491

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018522671A Active JP6983772B2 (ja) 2015-11-02 2016-11-01 タンパク質のフコシル化及び脱フコシル化形態の作製方法

Country Status (13)

Country Link
US (4) US10975168B2 (cg-RX-API-DMAC7.html)
EP (2) EP3371206B1 (cg-RX-API-DMAC7.html)
JP (1) JP6983772B2 (cg-RX-API-DMAC7.html)
KR (2) KR20250051156A (cg-RX-API-DMAC7.html)
CN (2) CN108431026B (cg-RX-API-DMAC7.html)
AU (2) AU2016350732A1 (cg-RX-API-DMAC7.html)
BR (1) BR112018007356A2 (cg-RX-API-DMAC7.html)
ES (1) ES2875274T3 (cg-RX-API-DMAC7.html)
IL (1) IL258161B2 (cg-RX-API-DMAC7.html)
MX (1) MX2018004831A (cg-RX-API-DMAC7.html)
PL (1) PL3371206T3 (cg-RX-API-DMAC7.html)
SG (2) SG10202103875WA (cg-RX-API-DMAC7.html)
WO (1) WO2017079165A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108431026B (zh) 2015-11-02 2023-02-17 豪夫迈·罗氏有限公司 制备岩藻糖基化和去岩藻糖基化形式的蛋白质的方法
JP6674028B2 (ja) * 2016-01-06 2020-04-01 アウトルック セラピューティクス,インコーポレイティド モノクローナル抗体組成物中のアフコシル化種の調節
WO2019011918A1 (en) 2017-07-10 2019-01-17 International - Drug - Development - Biotech TREATMENT OF LYMPHOCYTE B MALIGNANCIES USING AFUCOSYLATED PRO-APOPTOTIC ANTI-CD19 ANTIBODIES IN COMBINATION WITH ANTI-CD20 ANTIBODIES OR CHEMOTHERAPEUTIC AGENTS
US12325737B2 (en) * 2018-03-26 2025-06-10 Amgen Inc. Total afucosylated glycoforms of antibodies produced in cell culture
MA52783A (fr) 2018-06-05 2021-04-14 Amgen Inc Modulation de la phagocytose cellulaire dépendant de l'anticorps
WO2020042015A1 (en) * 2018-08-29 2020-03-05 United Biopharma Inc Afucosylated antibodies and manufacture thereof
EP3850006A1 (en) 2018-09-11 2021-07-21 Amgen Inc. Methods of modulating antibody-dependent cell-mediated cytotoxicity
HU231514B1 (hu) 2018-11-07 2024-07-28 Richter Gedeon Nyrt. Sejttenyészetben előállított rekombináns glikoprotein glikozilációs mintázatának megváltoztatására szolgáló módszer
DK3941946T3 (da) 2019-03-20 2025-03-24 Univ California Claudin-6-antistoffer og lægemiddelkonjugater
WO2020191344A1 (en) 2019-03-20 2020-09-24 The Regents Of The University Of California Claudin-6 bispecific antibodies
CN114144434A (zh) 2019-05-06 2022-03-04 美国安进公司 调节抗体效应子功能
KR20220069982A (ko) * 2019-09-26 2022-05-27 암젠 인크 항체 조성물의 생산 방법
EP4041773A1 (en) * 2019-10-11 2022-08-17 Beth Israel Deaconess Medical Center, Inc. Anti-tn antibodies and uses thereof
US20230265192A1 (en) * 2020-07-02 2023-08-24 Gigagen, Inc. Anti-ctla-4 binding proteins and methods of use thereof
AU2022289365A1 (en) 2021-06-07 2023-12-14 Amgen Inc. Using fucosidase to control afucosylation level of glycosylated proteins
US20250073323A1 (en) * 2021-08-06 2025-03-06 Anyadi, Llc Process for producing personalized cancer immunotherapy
KR102890992B1 (ko) * 2023-01-26 2025-12-02 팔라디바이오텍 주식회사 물질의 세포막 파괴 활성을 확인하는데 사용하기 위한 조성물, 및 그의 용도
WO2026117415A1 (en) * 2024-11-27 2026-06-04 Genentech, Inc. Afucosylation modification

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US30985A (en) 1860-12-18 Thomas l
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US4965195A (en) 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
WO1990003430A1 (en) 1988-09-23 1990-04-05 Cetus Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
WO1990005183A1 (en) 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
US6239328B1 (en) 1992-10-05 2001-05-29 North Carolina State University Method for reducing expression variability of transgenes in plant cells
US6037525A (en) 1996-08-01 2000-03-14 North Carolina State University Method for reducing expression variability of transgenes in plant cells
US6245974B1 (en) 1997-08-06 2001-06-12 North Carolina State University Matrix attachment regions
US6177612B1 (en) 1998-07-31 2001-01-23 Her Majesty The Queen In Right Of Canada, As Represented By The Department Of Agriculture And Agri-Food Canada Matrix attachment regions
AU762382B2 (en) 1998-09-29 2003-06-26 Pioneer Hi-Bred International, Inc. MAR/SAR elements flanking RSYN7-driven construct
KR100408844B1 (ko) 2000-07-29 2003-12-06 한국산업기술평가원 동물세포 발현벡터
US7259010B2 (en) 2000-12-15 2007-08-21 Pangen Biotech Inc. Expression vector for animal cell containing nuclear matrix attachment region of interferon beta
DK1395669T3 (da) 2001-01-26 2009-11-16 Selexis Sa Matriks bindingsregioner og fremgangsmåder til anvendelse af disse
PL213948B1 (pl) * 2001-10-25 2013-05-31 Genentech Inc Kompozycje zawierajace glikoproteine, czasteczka kwasu nukleinowego kodujaca te glikoproteine, komórka gospodarza, sposób wytwarzania glikoproteiny, kompozycja do zastosowania do leczenia, zastosowanie kompozycji i zestaw zawierajacy kompozycje
EP1694850B1 (en) 2003-11-12 2011-06-29 Schering Corporation Plasmid system for multigene expression
KR20080032065A (ko) * 2005-06-03 2008-04-14 제넨테크, 인크. 푸코실화 수준이 조절된 항체의 생성 방법
KR101318611B1 (ko) * 2005-07-22 2013-11-13 교와 핫꼬 기린 가부시키가이샤 유전자 재조합 항체 조성물
NZ576032A (en) * 2006-10-12 2012-03-30 Genentech Inc Antibodies to lymphotoxin-alpha
DK2808393T3 (en) * 2009-06-02 2018-03-12 Regeneron Pharma Cells insufficient for fucosylation
WO2010141855A1 (en) * 2009-06-05 2010-12-09 Momenta Pharmaceuticals, Inc. Methods of modulating fucosylation of glycoproteins
CN103597073B (zh) * 2011-03-06 2019-06-07 默克雪兰诺有限公司 低岩藻糖细胞系及其应用
WO2013013013A2 (en) * 2011-07-21 2013-01-24 Alnylam Pharmaceuticals, Inc. Compositions and methods for producing modified glycoproteins
PL3036320T5 (pl) * 2013-08-19 2024-06-10 Biogen Ma Inc. Kontrola glikozylacji białka poprzez parametry procesu suplementacji pożywki hodowlanej i hodowli komórkowej
EP3218490B1 (en) * 2014-11-15 2018-10-31 Zumutor Biologics, Inc. Dna-binding domain of crispr system for production of non-fucosylated and partially fucosylated proteins
US11267899B2 (en) * 2015-05-13 2022-03-08 Zumutor Biologics Inc. Afucosylated protein, cell expressing said protein and associated methods
CN108431026B (zh) 2015-11-02 2023-02-17 豪夫迈·罗氏有限公司 制备岩藻糖基化和去岩藻糖基化形式的蛋白质的方法

Similar Documents

Publication Publication Date Title
JP2016104045A5 (cg-RX-API-DMAC7.html)
Dinnis et al. Engineering mammalian cell factories for improved recombinant monoclonal antibody production: lessons from nature?
Ho et al. Generation of monoclonal antibody-producing mammalian cell lines
JP5592258B2 (ja) 製造方法
WO2019126634A3 (en) Targeted integration of nucleic acids
JP2012065652A5 (cg-RX-API-DMAC7.html)
JP2019523221A5 (cg-RX-API-DMAC7.html)
ZA201703241B (en) Anti-c5 antibodies and methods of use
Glinšek et al. CRISPR technologies in Chinese hamster ovary cell line engineering
JP2015525572A5 (cg-RX-API-DMAC7.html)
CN103597073A (zh) 低岩藻糖细胞系及其应用
SA518391704B1 (ar) C5 أجسام مضادة لـ وطرق لاستخدامها
EA201791633A1 (ru) Способ точной модификации растения посредством транзиентной экспрессии гена
PH12014500640A1 (en) Increasing virus-like particle yield in plants
JP2016513478A5 (cg-RX-API-DMAC7.html)
CR20200507A (es) Composiciones aav, métodos de fabricación y métodos de uso
Fischer et al. CHO cell engineering for improved process performance and product quality
JP7416745B2 (ja) 改変細胞、調製方法、及び構築物
JP2019500876A5 (cg-RX-API-DMAC7.html)
JP2017501749A5 (cg-RX-API-DMAC7.html)
EP4410970A3 (en) Efficient cell culture system for hepatitis c virus genotype 6a
JPWO2016190394A1 (ja) 核酸含有培地を用いた細胞培養方法
Park et al. Effects of palindrome structure on Dhfr amplification in Chinese hamster ovary cells
CN120752253A (zh) 具有经优化宿主细胞蛋白谱的cho细胞
Bolander et al. Pre-culture and BMP-2 stimulation under serum free conditions enhance proliferation, osteochondrogenic differentiation and BMP-signalling in human periosteum-derived cells